NO980420L - Anvendelse av griseofulvin for å inhibere cancervekst - Google Patents
Anvendelse av griseofulvin for å inhibere cancervekstInfo
- Publication number
- NO980420L NO980420L NO980420A NO980420A NO980420L NO 980420 L NO980420 L NO 980420L NO 980420 A NO980420 A NO 980420A NO 980420 A NO980420 A NO 980420A NO 980420 L NO980420 L NO 980420L
- Authority
- NO
- Norway
- Prior art keywords
- griseofulvin
- cancer growth
- inhibit cancer
- potentiators
- potentiator
- Prior art date
Links
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 title abstract 4
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 title abstract 4
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 title abstract 4
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 title abstract 4
- 229960002867 griseofulvin Drugs 0.000 title abstract 4
- 230000005907 cancer growth Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US183995P | 1995-08-03 | 1995-08-03 | |
| US67418196A | 1996-07-16 | 1996-07-16 | |
| PCT/US1996/012475 WO1997005870A2 (en) | 1995-08-03 | 1996-07-30 | Use of griseofulvin for inhibiting the growth of cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO980420D0 NO980420D0 (no) | 1998-01-30 |
| NO980420L true NO980420L (no) | 1998-04-03 |
Family
ID=26669547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO980420A NO980420L (no) | 1995-08-03 | 1998-01-30 | Anvendelse av griseofulvin for å inhibere cancervekst |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0841914A2 (cs) |
| JP (1) | JPH11511136A (cs) |
| KR (1) | KR19990036137A (cs) |
| AR (1) | AR003176A1 (cs) |
| AU (1) | AU713031B2 (cs) |
| BR (1) | BR9609920A (cs) |
| CA (1) | CA2228503A1 (cs) |
| CZ (1) | CZ30598A3 (cs) |
| HU (1) | HUP9903506A3 (cs) |
| IL (1) | IL123094A0 (cs) |
| MX (1) | MX9800945A (cs) |
| NO (1) | NO980420L (cs) |
| PL (1) | PL324905A1 (cs) |
| SK (1) | SK14298A3 (cs) |
| TR (1) | TR199800244T2 (cs) |
| WO (1) | WO1997005870A2 (cs) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
| US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
| US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
| US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
| US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
| US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
| US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
| WO2000006143A1 (en) * | 1998-07-27 | 2000-02-10 | Texas Pharmaceuticals, Inc. | Chemically induced intracellular hyperthermia |
| DK2055313T3 (en) * | 1998-11-09 | 2015-07-27 | Biogen Inc | Treatment of Hematologic Malignancies Related to Circulating Tumor Cells Using Chimeric Anti-CD20 Antibody |
| US6423734B1 (en) | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
| US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
| US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
| DE60238408D1 (de) * | 2001-06-25 | 2011-01-05 | Ajinomoto Kk | Antitumorale mittel |
| EP2008652A1 (en) * | 2007-06-28 | 2008-12-31 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| EP2204367A1 (en) | 2008-12-22 | 2010-07-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
-
1996
- 1996-07-30 AU AU66834/96A patent/AU713031B2/en not_active Ceased
- 1996-07-30 PL PL96324905A patent/PL324905A1/xx unknown
- 1996-07-30 EP EP96926807A patent/EP0841914A2/en not_active Withdrawn
- 1996-07-30 JP JP9508495A patent/JPH11511136A/ja active Pending
- 1996-07-30 IL IL12309496A patent/IL123094A0/xx unknown
- 1996-07-30 CA CA002228503A patent/CA2228503A1/en not_active Abandoned
- 1996-07-30 BR BR9609920A patent/BR9609920A/pt unknown
- 1996-07-30 SK SK142-98A patent/SK14298A3/sk unknown
- 1996-07-30 MX MX9800945A patent/MX9800945A/es unknown
- 1996-07-30 TR TR1998/00244T patent/TR199800244T2/xx unknown
- 1996-07-30 WO PCT/US1996/012475 patent/WO1997005870A2/en not_active Ceased
- 1996-07-30 HU HU9903506A patent/HUP9903506A3/hu unknown
- 1996-07-30 CZ CZ98305A patent/CZ30598A3/cs unknown
- 1996-07-30 KR KR1019980700805A patent/KR19990036137A/ko not_active Ceased
- 1996-08-02 AR ARP960103861A patent/AR003176A1/es not_active Application Discontinuation
-
1998
- 1998-01-30 NO NO980420A patent/NO980420L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL324905A1 (en) | 1998-06-22 |
| HUP9903506A3 (en) | 2000-07-28 |
| AU6683496A (en) | 1997-03-05 |
| WO1997005870A3 (en) | 1997-04-17 |
| KR19990036137A (ko) | 1999-05-25 |
| IL123094A0 (en) | 1998-09-24 |
| CZ30598A3 (cs) | 1998-06-17 |
| AR003176A1 (es) | 1998-07-08 |
| MX9800945A (es) | 1998-04-30 |
| BR9609920A (pt) | 1999-07-06 |
| JPH11511136A (ja) | 1999-09-28 |
| AU713031B2 (en) | 1999-11-18 |
| SK14298A3 (en) | 1998-09-09 |
| NO980420D0 (no) | 1998-01-30 |
| WO1997005870A2 (en) | 1997-02-20 |
| TR199800244T2 (xx) | 1998-09-21 |
| EP0841914A2 (en) | 1998-05-20 |
| HUP9903506A2 (hu) | 2000-06-28 |
| CA2228503A1 (en) | 1997-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO980420L (no) | Anvendelse av griseofulvin for å inhibere cancervekst | |
| CA2328368A1 (en) | Anti-inflammatory agents | |
| NO20002409L (no) | FremgangsmÕte for Õ produsere arsen trioksyd formuleringer og metoder for Õ behandle cancer ved Õ bruke arsen trioksyd eller melarsoprol | |
| ATE103813T1 (de) | Topische metronidazol-formulationen und deren verwendung als arzneimittel. | |
| AU2931500A (en) | Pharmaceutical composition containing nitrate source and an acidifying agent fortreating skin ischaemia | |
| AU9536898A (en) | 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| NO993654L (no) | Kit for Õ inhibere cancervekst, omfattende et kjemoterapeutisk middel og et benzimidazol og eventuelt en forsterker | |
| AU4385399A (en) | Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer | |
| NO975662L (no) | Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer | |
| EP0705098A4 (en) | METHOD FOR IMPROVING THE THERAPEUTIC EFFECTIVENESS OF ACTIVE SUBSTANCES FOR TREATING SOLID TUMORS AND OTHER DISEASES | |
| NO980473L (no) | Anvendelse av flukonazol for å inhibere cancervekst | |
| AU3902299A (en) | Methods of treating microbial infection and therapeutic formulations therefor | |
| NO953763L (no) | Heterocykel-holdige amidin-derivater, deres fremstilling og anvendelse | |
| AU563831B2 (en) | N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives | |
| DE69130063D1 (de) | Antivirales arzneimittel enthaltend prostratin | |
| DE69232596D1 (de) | Inhibitor von nebenwirkungen zur krebstherapy | |
| TR199903074T2 (xx) | Kanser tedavisinde HMG CoA ve farnesil transfer �nleyicileri. | |
| DK0980205T3 (da) | Anvendelse af en kombination af TALL-104 celler med adriamycin eller cisplatin i behandlingen af maligniteter | |
| CA2081911A1 (en) | Method and composition for treating psoriasis | |
| WO2023159048A3 (en) | Small molecule stat3 inhibitor for treating triple negative breast cancer | |
| AU1195092A (en) | Naphthoquinone derivatives for the treatment of chronic inflammation | |
| NO20012569L (no) | Anvendelse av aryl-substituerte syklobutylalkylaminer for behandling av urininkontinens | |
| BR0009289A (pt) | Uso de inibidores da vasopeptidase para tratar angina pectoris | |
| NO20020751L (no) | Kjemisk stabiliserte klorittlösninger for behandling av cancer og andre sykdommer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |